These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36707310)

  • 21. Switch therapy in full-term neonates with presumed or proven bacterial infection.
    Manzoni P; Esposito S; Gallo E; Gastaldo L; Farina D; Principi N
    J Chemother; 2009 Feb; 21(1):68-73. PubMed ID: 19297276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
    Elmore RL; Contois ME; Kelly J; Noe A; Poirier A
    Clin Ther; 1996; 18(2):246-55. PubMed ID: 8733985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of sulbactam/ampicillin in diluents for parenteral administration.
    Mushinsky RF; Reynolds ML; Nicholson CA; Crider LL; Forcier GA
    Rev Infect Dis; 1986; 8 Suppl 5():S523-7. PubMed ID: 3026000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacin.
    Phan M; Van der Auwera P; Andry G; Aoun M; Chantrain G; Deraemaecker R; Dor P; Daneau D; Ewalenko P; Meunier F
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2014-9. PubMed ID: 1416895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the physical compatibility of injectable enrofloxacin with commonly used intravenous fluids and drugs during simulated Y-port administration.
    Aghili A; Thomovsky EJ; Johnson PA; Brooks AC; Pierce TJ; Gochenauer AE
    Am J Vet Res; 2021 May; 82(5):358-366. PubMed ID: 33904804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic study of sulbactam and ampicillin administered concomitantly by intraarterial or intravenous infusion in the newborn.
    Sutton AM; Turner TL; Cockburn F; McAllister TA
    Rev Infect Dis; 1986; 8 Suppl 5():S518-22. PubMed ID: 3025999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit.
    Gikic M; Di Paolo ER; Pannatier A; Cotting J
    Pharm World Sci; 2000 Jun; 22(3):88-91. PubMed ID: 11028261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility profile of
    Sharma S; Banerjee T; Yadav G; Kumar A
    Front Cell Infect Microbiol; 2022; 12():1068840. PubMed ID: 36683677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications.
    Salamat-Miller N; Turner MA; Bandekar A; Dixit N; Jochim E; Mangum B; McPherson C; Tenjarla S; Singh S; Hwang YS; Barton N
    World J Pediatr; 2023 Jan; 19(1):58-67. PubMed ID: 36344872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units.
    Kanji S; Lam J; Johanson C; Singh A; Goddard R; Fairbairn J; Lloyd T; Monsour D; Kakal J
    Crit Care Med; 2010 Sep; 38(9):1890-8. PubMed ID: 20562698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis.
    Lorenzen JM; Broll M; Kaever V; Burhenne H; Hafer C; Clajus C; Knitsch W; Burkhardt O; Kielstein JT
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):385-90. PubMed ID: 22223613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The elimination of gentamicin-resistant gram-negative bacteria in a newborn intensive care unit.
    Raz R; Sharir R; Shmilowitz L; Kenes I; Ephros M
    Infection; 1987; 15(1):32-4. PubMed ID: 3646180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixing and compatibility guide for commonly used aerosolized medications.
    Burchett DK; Darko W; Zahra J; Noviasky J; Probst L; Smith A
    Am J Health Syst Pharm; 2010 Feb; 67(3):227-30. PubMed ID: 20101066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016.
    Gandra S; Alvarez-Uria G; Murki S; Singh SK; Kanithi R; Jinka DR; Chikkappa AK; Subramanian S; Sharma A; Dharmapalan D; Kandraju H; Vasudevan AK; Tunga O; Akula A; Hsia Y; Sharland M; Laxminarayan R
    Int J Infect Dis; 2018 Jun; 71():20-24. PubMed ID: 29608958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.
    Cuzzolin L; Agostino R
    Eur J Clin Pharmacol; 2016 Jan; 72(1):117-23. PubMed ID: 26490354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
    Shafiee F; Naji Esfahani SS; Hakamifard A; Soltani R
    Indian J Med Microbiol; 2021 Jul; 39(3):358-362. PubMed ID: 33906750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of multidrug-resistant
    Sun L; Wang X; Li Z
    Br J Neurosurg; 2018 Dec; 32(6):642-645. PubMed ID: 28431478
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines].
    Costa HTML; Florencio AP; Bezerra PKDV; Cavalcanti JEC; Costa TX; Fernandes FEM; Martins RR
    An Pediatr (Engl Ed); 2021 Mar; 94(3):153-160. PubMed ID: 33514478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential intravenous drug incompatibilities in a pediatric unit.
    Leal KD; Leopoldino RW; Martins RR; Veríssimo LM
    Einstein (Sao Paulo); 2016; 14(2):185-9. PubMed ID: 27462891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of ampicillin/sulbactam in patients undergoing spinal microneurosurgical procedures.
    Warnke JP; Wildfeuer A; Eibel G; Pfaff G; Klammer A
    Int J Clin Pharmacol Ther; 1998 May; 36(5):253-7. PubMed ID: 9629988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.